Olajide, OA and Sarker, SD Alzheimer’s disease: Natural products as inhibitors of neuroinflammation. Inflammopharmacology. ISSN 0925-4692 (Accepted)

Text AntineuroinflammatoryNP_Accepted260820.pdf - Accepted Version Restricted to Repository staff only Download (535kB)

Abstract

Alzheimer’s disease (AD) is the most common form of dementia and affects 44 million people worldwide. New emerging evidence from pre-clinical and clinical investigations shows that neuroinflammation is a major pathological component of AD suggesting that anti-inflammatory strategies are important in delaying the onset or slowing the progression of the disease. However, efforts to employ current anti-inflammatory agents in AD clinical trials have produced limited success. Consequently, there is a need to explore anti-inflammatory natural products, which target neuroinflammatory pathways relevant to AD pathogenesis. This review summarises important druggable molecular targets of neuroinflammation and presents classes of anti-neuroinflammatory natural products with potentials for preventing and reducing symptoms of AD.

Item Type:	Article
Uncontrolled Keywords:	1115 Pharmacology and Pharmaceutical Sciences
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Pharmacy & Biomolecular Sciences
Publisher:	Springer Verlag
Date Deposited:	26 Aug 2020 14:55
Last Modified:	26 Aug 2020 15:00
URI:	https://researchonline.ljmu.ac.uk/id/eprint/13552

Actions (login required)

View Item